ATE395914T1 - Asenapin zur behandlung von schizophrenie bei einem patienten mit übergewicht oder veranlagung zu übergewicht - Google Patents
Asenapin zur behandlung von schizophrenie bei einem patienten mit übergewicht oder veranlagung zu übergewichtInfo
- Publication number
- ATE395914T1 ATE395914T1 AT04766041T AT04766041T ATE395914T1 AT E395914 T1 ATE395914 T1 AT E395914T1 AT 04766041 T AT04766041 T AT 04766041T AT 04766041 T AT04766041 T AT 04766041T AT E395914 T1 ATE395914 T1 AT E395914T1
- Authority
- AT
- Austria
- Prior art keywords
- overweight
- asenapine
- schizophrenia
- patient
- presented
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101721 | 2003-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395914T1 true ATE395914T1 (de) | 2008-06-15 |
Family
ID=33547705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04766041T ATE395914T1 (de) | 2003-06-12 | 2004-06-09 | Asenapin zur behandlung von schizophrenie bei einem patienten mit übergewicht oder veranlagung zu übergewicht |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20060128688A1 (de) |
| EP (1) | EP1635820B1 (de) |
| JP (1) | JP2006527238A (de) |
| KR (1) | KR20060020664A (de) |
| CN (1) | CN1816335A (de) |
| AR (1) | AR044675A1 (de) |
| AT (1) | ATE395914T1 (de) |
| AU (1) | AU2004246820B2 (de) |
| BR (1) | BRPI0411237A (de) |
| CA (1) | CA2528365A1 (de) |
| CY (1) | CY1110366T1 (de) |
| DE (1) | DE602004013966D1 (de) |
| DK (1) | DK1635820T3 (de) |
| ES (1) | ES2305829T3 (de) |
| HK (1) | HK1084894A1 (de) |
| IL (1) | IL172397A (de) |
| NO (1) | NO20055884L (de) |
| NZ (1) | NZ544018A (de) |
| PL (1) | PL1635820T3 (de) |
| PT (1) | PT1635820E (de) |
| RU (1) | RU2352336C2 (de) |
| SI (1) | SI1635820T1 (de) |
| TW (1) | TWI327915B (de) |
| WO (1) | WO2004110437A1 (de) |
| ZA (1) | ZA200509904B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2603509C (en) * | 2005-04-07 | 2013-12-03 | N.V. Organon | Crystal form of asenapine maleate |
| US7741358B2 (en) | 2005-04-14 | 2010-06-22 | N.V. Organon | Crystal form of asenapine maleate |
| RU2762896C2 (ru) | 2016-12-20 | 2021-12-23 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин |
| RU2764443C2 (ru) * | 2016-12-20 | 2022-01-17 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин и полисилоксан или полиизобутилен |
| WO2019002204A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER |
| CN112704672A (zh) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| WO2020106330A1 (en) * | 2018-07-18 | 2020-05-28 | Pillsy, Inc. | Smart drug delivery and monitoring device, kit, and method of use for pill compounds |
| AU2020400061A1 (en) | 2019-12-11 | 2022-04-14 | Corcept Therapeutics Incorporated | Methods of treating antipsychotic-induced weight gain with miricorilant |
| RU2756614C1 (ru) * | 2021-04-07 | 2021-10-04 | Федеральное государственное бюджетное научное учреждение «Томский национальный исследовательский медицинский центр Российской академии наук» (Томский НИМЦ) | Способ поддержки принятия врачебных решений выбора антипсихотической терапии у больных шизофренией с целью профилактики акатизии |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2182981C (en) * | 1994-03-02 | 2006-10-17 | Leonardus Petrus Carla Delbressine | Sublingual or buccal pharmaceutical composition |
| US5496831A (en) * | 1994-05-13 | 1996-03-05 | The General Hospital Corporation | Inhibition of insulin-induced adiposis |
| CA2431041A1 (en) * | 2001-01-02 | 2002-07-11 | Pharmacia & Upjohn Company | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
-
2004
- 2004-06-03 TW TW093116017A patent/TWI327915B/zh not_active IP Right Cessation
- 2004-06-09 AU AU2004246820A patent/AU2004246820B2/en not_active Ceased
- 2004-06-09 PT PT04766041T patent/PT1635820E/pt unknown
- 2004-06-09 SI SI200430755T patent/SI1635820T1/sl unknown
- 2004-06-09 US US10/560,554 patent/US20060128688A1/en not_active Abandoned
- 2004-06-09 CN CNA200480018591XA patent/CN1816335A/zh active Pending
- 2004-06-09 JP JP2006516141A patent/JP2006527238A/ja active Pending
- 2004-06-09 WO PCT/EP2004/051069 patent/WO2004110437A1/en active IP Right Grant
- 2004-06-09 CA CA002528365A patent/CA2528365A1/en not_active Abandoned
- 2004-06-09 RU RU2006101061/14A patent/RU2352336C2/ru not_active IP Right Cessation
- 2004-06-09 DK DK04766041T patent/DK1635820T3/da active
- 2004-06-09 PL PL04766041T patent/PL1635820T3/pl unknown
- 2004-06-09 NZ NZ544018A patent/NZ544018A/en not_active IP Right Cessation
- 2004-06-09 AT AT04766041T patent/ATE395914T1/de active
- 2004-06-09 KR KR1020057023646A patent/KR20060020664A/ko not_active Application Discontinuation
- 2004-06-09 BR BRPI0411237-7A patent/BRPI0411237A/pt not_active IP Right Cessation
- 2004-06-09 EP EP04766041A patent/EP1635820B1/de not_active Not-in-force
- 2004-06-09 ES ES04766041T patent/ES2305829T3/es active Active
- 2004-06-09 DE DE602004013966T patent/DE602004013966D1/de active Active
- 2004-06-11 AR ARP040102026A patent/AR044675A1/es unknown
-
2005
- 2005-12-06 IL IL172397A patent/IL172397A/en not_active IP Right Cessation
- 2005-12-06 ZA ZA200509904A patent/ZA200509904B/en unknown
- 2005-12-12 NO NO20055884A patent/NO20055884L/no not_active Application Discontinuation
-
2006
- 2006-06-28 HK HK06107276A patent/HK1084894A1/xx not_active IP Right Cessation
-
2008
- 2008-06-24 CY CY20081100659T patent/CY1110366T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004246820A1 (en) | 2004-12-23 |
| NO20055884L (no) | 2006-01-03 |
| RU2006101061A (ru) | 2006-07-27 |
| BRPI0411237A (pt) | 2006-07-11 |
| ZA200509904B (en) | 2006-12-27 |
| IL172397A0 (en) | 2006-04-10 |
| CA2528365A1 (en) | 2004-12-23 |
| CN1816335A (zh) | 2006-08-09 |
| WO2004110437A1 (en) | 2004-12-23 |
| SI1635820T1 (sl) | 2008-08-31 |
| TW200501946A (en) | 2005-01-16 |
| US20060128688A1 (en) | 2006-06-15 |
| EP1635820A1 (de) | 2006-03-22 |
| CY1110366T1 (el) | 2014-04-09 |
| PT1635820E (pt) | 2008-06-17 |
| ES2305829T3 (es) | 2008-11-01 |
| RU2352336C2 (ru) | 2009-04-20 |
| AU2004246820B2 (en) | 2009-10-01 |
| IL172397A (en) | 2010-06-16 |
| JP2006527238A (ja) | 2006-11-30 |
| NZ544018A (en) | 2008-07-31 |
| AR044675A1 (es) | 2005-09-21 |
| TWI327915B (en) | 2010-08-01 |
| DK1635820T3 (da) | 2008-09-08 |
| DE602004013966D1 (de) | 2008-07-03 |
| HK1084894A1 (en) | 2006-08-11 |
| PL1635820T3 (pl) | 2008-10-31 |
| KR20060020664A (ko) | 2006-03-06 |
| EP1635820B1 (de) | 2008-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| DE602004010419D1 (de) | Triazaspiropiperidinderivate zur verwendung als glyt-1-inhibitoren bei der behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| ATE499105T1 (de) | Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen | |
| ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
| ATE414556T1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
| ATE413178T1 (de) | 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE602005020293D1 (de) | Zur behandlung von hyperproliferationserkrankungen und mit angiogenese assoziierten krankheiten geeignete pyrrolotriazinderivate | |
| ATE446102T1 (de) | Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii | |
| DE60335293D1 (de) | Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen | |
| ATE340568T1 (de) | Verwendung einer pharmazeutischen formulierung enthaltend milchsäure oder laktat und kalium zur behandlung von hirnödem und verletzungen des gehirns | |
| GB2410919B (en) | Improvements in or relating to the treatment of waste | |
| ATE410169T1 (de) | Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust | |
| ATE395914T1 (de) | Asenapin zur behandlung von schizophrenie bei einem patienten mit übergewicht oder veranlagung zu übergewicht | |
| ATE427928T1 (de) | Fluorobenzamide zur behandlung von alzheimer oder seniler dementia | |
| ATE429221T1 (de) | Medikamente zur behandlung oder prävention fibrotischer krankheiten | |
| DE60234861D1 (de) | Verfahren zur behandlung von pulveriger kautschuk um die oberfläche uneben zu machen | |
| ATE423099T1 (de) | Zur behandlung von schmerzen geeignete piperazine | |
| DK1670482T4 (da) | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme | |
| IL178970A0 (en) | Haplotype markers and methods of using the same to determine response to treatment | |
| DE60224004D1 (de) | Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
| ATE418337T1 (de) | Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden | |
| ATE257384T1 (de) | Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen | |
| ATE347369T1 (de) | Verfahren zur stimulierung des wachstums und des widerstands gegen erkrankungen von wasserorganismen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1635820 Country of ref document: EP |